EQNSX
Price
$23.16
Change
+$0.08 (+0.35%)
Updated
Jul 25 closing price
Net Assets
668.42M
VIVIX
Price
$70.44
Change
+$0.29 (+0.41%)
Updated
Jul 25 closing price
Net Assets
195.18B
Interact to see
Advertisement

EQNSX vs VIVIX

Header iconEQNSX vs VIVIX Comparison
Open Charts EQNSX vs VIVIXBanner chart's image
MFS Equity Income R2
Price$23.16
Change+$0.08 (+0.35%)
VolumeN/A
Net Assets668.42M
Vanguard Value Index I
Price$70.44
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets195.18B
EQNSX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EQNSX vs. VIVIX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNSX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 195B vs. EQNSX (668M). VIVIX pays higher dividends than EQNSX: VIVIX (2.19) vs EQNSX (1.72). EQNSX was incepted earlier than VIVIX: EQNSX (13 years) vs VIVIX (27 years). EQNSX (1.20) is less costly to investors than VIVIX (0.04). EQNSX is a more actively managed with annual turnover of: 45.00 vs. VIVIX (9.00). EQNSX has a lower initial minimum investment than VIVIX: EQNSX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 9.75 vs. EQNSX (8.27). VIVIX return over 5 years is better than : 74.87 vs. EQNSX (64.60).
EQNSXVIVIXEQNSX / VIVIX
Total Expense Ratio1.140.042,850%
Annual Report Gross Expense Ratio1.200.043,000%
Fund Existence13 years27 years-
Gain YTD11.0186.730164%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets668M195B0%
Annual Yield % from dividends1.722.1978%
Returns for 1 year8.279.7585%
Returns for 3 years36.3434.32106%
Returns for 5 years64.6074.8786%
Returns for 10 years100.49116.2686%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATHE6.550.87
+15.32%
Alterity Therapeutics Limited
HDSN8.530.25
+3.08%
Hudson Technologies
DEI15.550.05
+0.32%
Douglas Emmett
DVA145.170.40
+0.28%
DaVita
DRMA0.70N/A
-0.01%
Dermata Therapeutics Inc.